Your browser is no longer supported. Please, upgrade your browser.
Settings
CHMA [NASD]
Chiasma, Inc.
Index- P/E- EPS (ttm)-1.48 Insider Own0.30% Shs Outstand62.88M Perf Week-6.49%
Market Cap167.16M Forward P/E- EPS next Y-0.66 Insider Trans204.93% Shs Float57.42M Perf Month-14.54%
Income-74.80M PEG- EPS next Q-0.30 Inst Own70.30% Short Float5.09% Perf Quarter-29.24%
Sales1.10M P/S151.96 EPS this Y-34.80% Inst Trans-4.57% Short Ratio1.66 Perf Half Y-26.34%
Book/sh1.46 P/B1.97 EPS next Y40.50% ROA-54.20% Target Price- Perf Year-28.80%
Cash/sh2.33 P/C1.23 EPS next 5Y46.30% ROE-91.80% 52W Range2.77 - 7.75 Perf YTD-33.79%
Dividend- P/FCF- EPS past 5Y15.10% ROI-77.10% 52W High-62.84% Beta1.31
Dividend %- Quick Ratio8.50 Sales past 5Y- Gross Margin94.50% 52W Low3.97% ATR0.20
Employees85 Current Ratio9.20 Sales Q/Q- Oper. Margin- RSI (14)36.62 Volatility4.47% 6.16%
OptionableYes Debt/Eq0.00 EPS Q/Q-10.10% Profit Margin- Rel Volume0.48 Prev Close2.82
ShortableYes LT Debt/Eq0.00 EarningsMar 04 AMC Payout- Avg Volume1.77M Price2.88
Recom1.80 SMA20-8.74% SMA50-20.47% SMA200-32.37% Volume844,638 Change2.13%
Aug-13-20Initiated Jefferies Buy $8
Jul-31-19Initiated Piper Jaffray Overweight $11
Feb-14-19Initiated H.C. Wainwright Buy $11
Jan-17-17Downgrade Barclays Equal Weight → Underweight $5.50 → $2.50
Apr-25-16Downgrade Barclays Overweight → Equal Weight $40 → $5.50
Aug-10-15Initiated Barclays Overweight $40
Mar-22-21 04:01PM  
Mar-20-21 11:00AM  
Mar-14-21 04:14AM  
Mar-10-21 08:00AM  
Mar-05-21 12:31AM  
Mar-04-21 05:25PM  
04:01PM  
03:15PM  
Mar-02-21 08:00AM  
Feb-25-21 08:00AM  
Feb-06-21 02:19AM  
Jan-19-21 07:00AM  
Jan-07-21 08:20AM  
Jan-06-21 04:01PM  
Dec-23-20 12:25AM  
Dec-15-20 11:26PM  
Nov-23-20 08:00AM  
Nov-20-20 08:00AM  
Nov-18-20 07:29AM  
07:00AM  
Nov-16-20 08:00AM  
Nov-08-20 08:25AM  
07:37AM  
Nov-06-20 01:01AM  
Nov-05-20 04:05PM  
03:45PM  
Oct-30-20 08:00AM  
Oct-29-20 08:00AM  
Oct-01-20 07:00AM  
Sep-24-20 10:46AM  
Sep-08-20 08:00AM  
Aug-31-20 08:00AM  
Aug-17-20 02:01PM  
08:00AM  
Aug-11-20 02:30AM  
Aug-10-20 04:05PM  
Aug-03-20 04:01PM  
Jul-27-20 04:01PM  
Jul-08-20 09:21PM  
Jul-01-20 11:53AM  
09:05AM  
08:55AM  
Jun-30-20 04:30PM  
Jun-29-20 09:52AM  
Jun-26-20 01:28PM  
08:28AM  
Jun-16-20 06:14AM  
Jun-04-20 08:28PM  
May-08-20 04:30PM  
May-07-20 04:05PM  
Apr-30-20 04:01PM  
Apr-22-20 04:45PM  
Apr-08-20 07:00AM  
Mar-31-20 04:56PM  
Mar-16-20 04:05PM  
03:00PM  
Mar-09-20 04:05PM  
Feb-06-20 10:40AM  
Jan-26-20 09:17AM  
Jan-13-20 07:00AM  
Jan-10-20 07:00AM  
Dec-20-19 08:12AM  
Dec-19-19 04:05PM  
Dec-14-19 08:59PM  
Nov-26-19 04:05PM  
Nov-22-19 02:27AM  
Nov-14-19 04:05PM  
Nov-11-19 09:39AM  
Nov-05-19 04:05PM  
Nov-01-19 08:00AM  
Oct-29-19 08:00AM  
Oct-28-19 07:26AM  
Sep-25-19 08:00AM  
Sep-18-19 06:30AM  
Sep-17-19 09:00AM  
Sep-13-19 08:19AM  
Sep-05-19 04:05PM  
Aug-31-19 10:23PM  
Aug-16-19 09:00AM  
Aug-09-19 01:23PM  
Aug-08-19 04:05PM  
Aug-01-19 04:05PM  
Jul-31-19 01:48PM  
Jul-26-19 09:06AM  
Jul-25-19 04:01PM  
Jul-23-19 09:39AM  
06:00AM  
Jul-15-19 12:55PM  
Jun-28-19 02:19PM  
07:32AM  
Jun-27-19 04:10PM  
04:05PM  
Jun-06-19 07:37AM  
Jun-05-19 04:05PM  
May-30-19 08:50AM  
05:59AM  
May-24-19 06:52AM  
May-14-19 04:05PM  
May-09-19 06:45PM  
04:05PM  
Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mamluk RoniDirectorFeb 09Option Exercise1.8527,98151,76527,981Feb 11 05:39 PM
Mamluk RoniDirectorFeb 09Sale5.0027,981139,9050Feb 11 05:39 PM
Fitzpatrick Mark J.PresidentDec 04Option Exercise2.6010,00026,00019,612Dec 07 04:35 PM
STACK DAVID MDirectorNov 30Buy4.2725,000106,85825,000Dec 01 07:40 PM
KANNAN RAJChief Executive OfficerNov 23Buy4.00120,000480,492137,095Nov 24 06:01 PM
KANNAN RAJChief Executive OfficerJul 14Buy4.2010,00042,00017,095Jul 15 06:57 PM